Amit Verma
About Amit Verma
Amit Verma serves as the Vice President of Commercial at Deciphera Pharmaceuticals, where he has worked since 2019. He has extensive experience in the pharmaceutical industry, having held various leadership roles at companies such as Novartis, Millennium Pharmaceuticals, and AMAG Pharmaceuticals.
Work at Deciphera Pharmaceuticals
Amit Verma serves as the Vice President of Commercial at Deciphera Pharmaceuticals since 2019. In this role, he has guided asset development from pre-IND through the end of Phase 2/3, ensuring commercial preparation. This includes the development of Target Product Profiles (TPP), preliminary pricing strategies, positioning, forecasting, and go-to-market plans. He has also led the development of New Product Planning and Global Marketing groups, contributing to the company's strategic direction and market readiness.
Previous Experience in Pharmaceuticals
Prior to his current role, Amit Verma held various positions in the pharmaceutical industry. He worked at Novartis Pharmaceuticals for 11 years, where he took on various roles with increasing responsibilities. He then served as Senior Director of Velcade Marketing at Millennium Pharmaceuticals, Inc. for one year. His experience also includes a position as Senior Director of Marketing at MedImmune for three years and as Vice President of Marketing at AMAG Pharmaceuticals for six years. Additionally, he was Associate Vice President and Global Commercial Lead for Oncology at sanofi-aventis for three years.
Education and Expertise
Amit Verma holds a Bachelor's degree in Psychology from Hamilton College. He furthered his education by obtaining a Master of Business Administration (MBA) with a focus on Marketing from Columbia University - Columbia Business School. His educational background supports his expertise in commercial strategy and marketing within the pharmaceutical industry.
Achievements in Product Launches
Amit Verma successfully managed the pre-launch and launch preparation for Qinlock during the COVID-19 pandemic at Deciphera Pharmaceuticals. His efforts exceeded all internal and external launch metrics, demonstrating his capability in navigating complex market conditions. He has also played a significant role in assets' life cycle management and was instrumental in building out the European Union infrastructure as part of the Global Implementation team.